Effect of Ursolic Acid on Breast Cancer Resistance Protein-mediated Transport of Rosuvastatin In Vi v o and Vitro
Objective To evaluate whether ursolic acid can inhibit breast cancer resistance protein (BCRP)-mediatedtransport of rosuvastatin in vivo and in vitro. Methods Firstly, we explored the pharmacokinetics of 5-fluorouracil (5-FU, a substrate ofBCRP) in rats in the presence or absence of ursolic acid. Se...
Saved in:
Published in | 中国医学科学杂志:英文版 no. 4; pp. 218 - 225 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
2015
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Objective To evaluate whether ursolic acid can inhibit breast cancer resistance protein (BCRP)-mediatedtransport of rosuvastatin in vivo and in vitro. Methods Firstly, we explored the pharmacokinetics of 5-fluorouracil (5-FU, a substrate ofBCRP) in rats in the presence or absence of ursolic acid. Secondly, we studied the pharmacokinetics ofrosuvastatin in rats in the presence or absence of ursolic acid or Ko143 (inhibitor of BCRP). Finially, theconcentration-dependent transport of rosuvastatin and the inhibitory effects of ursolic acid and Ko143were examined in Madin-Darby Canine Kidney (MDCK) II-BCRP421CC (wild type) cells andMDCK II -BCRP421AA (mutant type) cells. Results As a result, significant changes in pharmacokinetics parameters of 5-FU were observedin rats following pretreatment with ursolic acid. Both ursolic acid and Ko143 could significantly affectthe pharmacokinetics of rosuvastatin. The rosuvastatin transport in the BCRP overexpressing system wasincreased in a concentration-dependent manner. However, there was no statistical difference inBCRP-mediated transport of rosuvastatin betweent the wild type cells and mutant cells. The same asKo143, ursolic acid inhibited BCRP-mediated transport of rosuvastatin in vitro. Conclusion Ursolic acid appears to be a potent modulator of BCRP that affects the pharmacokineticof rosuvastatin in vivo and inhibits the transport of rosuvastatin in vitro. |
---|---|
AbstractList | Objective To evaluate whether ursolic acid can inhibit breast cancer resistance protein (BCRP)-mediatedtransport of rosuvastatin in vivo and in vitro. Methods Firstly, we explored the pharmacokinetics of 5-fluorouracil (5-FU, a substrate ofBCRP) in rats in the presence or absence of ursolic acid. Secondly, we studied the pharmacokinetics ofrosuvastatin in rats in the presence or absence of ursolic acid or Ko143 (inhibitor of BCRP). Finially, theconcentration-dependent transport of rosuvastatin and the inhibitory effects of ursolic acid and Ko143were examined in Madin-Darby Canine Kidney (MDCK) II-BCRP421CC (wild type) cells andMDCK II -BCRP421AA (mutant type) cells. Results As a result, significant changes in pharmacokinetics parameters of 5-FU were observedin rats following pretreatment with ursolic acid. Both ursolic acid and Ko143 could significantly affectthe pharmacokinetics of rosuvastatin. The rosuvastatin transport in the BCRP overexpressing system wasincreased in a concentration-dependent manner. However, there was no statistical difference inBCRP-mediated transport of rosuvastatin betweent the wild type cells and mutant cells. The same asKo143, ursolic acid inhibited BCRP-mediated transport of rosuvastatin in vitro. Conclusion Ursolic acid appears to be a potent modulator of BCRP that affects the pharmacokineticof rosuvastatin in vivo and inhibits the transport of rosuvastatin in vitro. |
Author | Jin-hua Wen Xiao-hua Wei Xiang-yuan Sheng De-qing Zhou Hong-wei Peng Yan-ni Lu Jian Zhou |
AuthorAffiliation | Department of Pharmacy, the First Affiliated Hospital of Nanchang University,Nanchang 330006, China |
Author_xml | – sequence: 1 fullname: Jin-hua Wen Xiao-hua Wei Xiang-yuan Sheng De-qing Zhou Hong-wei Peng Yan-ni Lu Jian Zhou |
BookMark | eNqNjsFqwlAQRd9CQWP7D0P3gZc0pHXZimJ3Jdhu5fEy0Sk6ozOvAf_etPgBru5Z3HO5mRuxMI7ctPC-yOflvJq4zOzHe18Xr9XUnZddhzGBdPClJgeK8BapBWF4VwyWYBE4okKDRpb-GD5VEhLnR2wpJGxho4HtJPo_04j99oMYEjF8MHwT9CAQuB0wqTy4cRcOho-3nLmn1XKzWOdxL7w7E--2J6Vj0Mu2rl-G22VRPd9VugLvKEpg |
ContentType | Journal Article |
DBID | 2RA 92L CQIGP W91 ~WA |
DatabaseName | 维普_期刊 中文科技期刊数据库-CALIS站点 维普中文期刊数据库 中文科技期刊数据库-医药卫生 中文科技期刊数据库- 镜像站点 |
DatabaseTitleList | |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Biology Pharmacy, Therapeutics, & Pharmacology |
EndPage | 225 |
ExternalDocumentID | 667001214 |
GroupedDBID | --- --K -05 -0E -SE -S~ .~1 0R~ 1B1 1~. 1~5 29B 2B. 2C~ 2RA 4.4 457 4G. 53G 5GY 5VR 5VS 5XA 5XF 5XL 7-5 71M 92F 92I 92L 92M 93N 93R 9D9 9DE AAEDT AALRI AAQFI AAXUO ABBQC ABKZE ADMUD AEKER AFTJW AFUIB AGYEJ AITUG AJRQY ALMA_UNASSIGNED_HOLDINGS CAJEE CAJUS CCEZO CHBEP CIEJG CQIGP CW9 DU5 EBS EJD EP2 EP3 FA0 FDB FNPLU GBLVA HZ~ J1W JUIAU M41 MO0 N9A O-L O9- OZT P-8 P-9 PC. Q-- Q-4 Q38 R-E RIG ROL RT5 S.. SDF SES T8U TCJ TGQ U1F U1G U5E U5O W91 WFFXF ~WA |
ID | FETCH-chongqing_primary_6670012143 |
ISSN | 1001-9294 |
IngestDate | Wed Feb 14 10:24:35 EST 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 4 |
Language | English |
LinkModel | OpenURL |
MergedId | FETCHMERGED-chongqing_primary_6670012143 |
Notes | 11-2752/R |
ParticipantIDs | chongqing_primary_667001214 |
PublicationCentury | 2000 |
PublicationDate | 2015 |
PublicationDateYYYYMMDD | 2015-01-01 |
PublicationDate_xml | – year: 2015 text: 2015 |
PublicationDecade | 2010 |
PublicationTitle | 中国医学科学杂志:英文版 |
PublicationTitleAlternate | Chinese Medical Sciences Journal |
PublicationYear | 2015 |
SSID | ssj0006184 |
Score | 3.9903033 |
Snippet | Objective To evaluate whether ursolic acid can inhibit breast cancer resistance protein (BCRP)-mediatedtransport of rosuvastatin in vivo and in vitro. Methods... |
SourceID | chongqing |
SourceType | Publisher |
StartPage | 218 |
SubjectTerms | acid breast cancer protein resistance rosuvastatin transport ursolic |
Title | Effect of Ursolic Acid on Breast Cancer Resistance Protein-mediated Transport of Rosuvastatin In Vi v o and Vitro |
URI | http://lib.cqvip.com/qk/86798X/201504/667001214.html |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Rb9MwELaqSSBeEBQQbIAsxO0ly7RkWeI8Jl2qUjHUh64UXqakTVa_2KxLisoDv527OErDhCbgJXLOjuvmPl_O57szY-_TwM1QEXftPA1ObM9d4JwriqWNH2cn9Zfusjil4OSLT_7o0hvPz-a9XtdrqSqz48WPP8aV_A9XkYZ8pSjZf-Bs2ykSsIz8xStyGK9_xeMm9TDqe5d07LVcWNFCLsn-H5OveWkNiKdrstGTmkhzeEJ5GaSy64gR0jbb7OZ1WhJ9W21SCjKSZCy0ZtLaWLreYJjJcq27qiwkHsQConNIziCMIa4LYgBxTAWkRz4kAUQBhE6H4kN4DsIlSjyEMIBkCPEAwggSAQL7ceo2PoiAHhchiNbddowjX1Wp9TlX1lymurmRdKOu7W1F0mqVq2uUo_YNWUG-rnRljTRWfsdmE6r6kipbSetjZY1JulGLru3DxH02gppcwVC18zoY9X4TxKLzTXdNcPWdzNo-hSg5bn0MOiUZQml4_HPnIERH4dR75c0vUfaNFY6XRt_RQaZP2ONm8cAjg4SnrJerPntgjhPd9tnDi8ZRos8OJyYl-faIT3cRdrdH_JBPdsnKt8_YjcEQ1wVvMMQJQ1wrbjDEDYb4DkP8LoZ4iyHqposh_kHxmeQbrjliiNcYes7eDZPpYGS3f_Pqm0l5ctW-qtMXbE9plb9kXBQ4k_3Aw0UwruEzJxULl_bx_CLNHP-keMUO7ulo_97aA_aI-G1sXa_ZXrmu8jeo_ZXZ25pJvwD_nVli |
link.rule.ids | 315,786,790,4043 |
linkProvider | Elsevier |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Effect+of+Ursolic+Acid+on+Breast+Cancer+Resistance+Protein-mediated+Transport+of+Rosuvastatin+In+Vi+v+o+and+Vitro&rft.jtitle=%E4%B8%AD%E5%9B%BD%E5%8C%BB%E5%AD%A6%E7%A7%91%E5%AD%A6%E6%9D%82%E5%BF%97%EF%BC%9A%E8%8B%B1%E6%96%87%E7%89%88&rft.au=Jin-hua+Wen+Xiao-hua+Wei+Xiang-yuan+Sheng+De-qing+Zhou+Hong-wei+Peng+Yan-ni+Lu+Jian+Zhou&rft.date=2015&rft.issn=1001-9294&rft.issue=4&rft.spage=218&rft.epage=225&rft.externalDocID=667001214 |
thumbnail_s | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=http%3A%2F%2Fimage.cqvip.com%2Fvip1000%2Fqk%2F86798X%2F86798X.jpg |